advertisement
14 Costing studies; pharmacoeconomics (2)
Showing records 1 to 2
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics21468 Costs and persistence of carbonic anhydrase inhibitor versus α-2 agonists, associated with β-blockers, in glaucoma and ocular hypertension: An analysis of the UK-GPRD database
Lafuma A; Berdeaux G
Current Medical Research and Opinion 2008; 24: 1519-1527
21472 Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries
Thygesen J; Aagren M; Arnavielle S; Bron A; Frohlich SJ; Baggesen K; Azuara-Blanco A; Buchholz P; Walt JG
Current Medical Research and Opinion 2008; 24: 1763-1770
